Next generation investment company
Need help?Сontacts
Phone  +356 2015 0555 Call us 24/7

We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.

Canadian medical cannabis producer Tilray launches IPO

Canadian medical cannabis producer Tilray launches IPO

NASDAQ now offers some unusual shares: Tilray, a global leader in medical cannabis research, cultivation, processing, and distribution, launched the first IPO in this sphere. Tilray is offering 9 million shares of Class 2 at the opening price of $23,05 per share. The company intends to grant underwriters a 30-day over-allotment option to purchase up to 1,350,000 of additional shares.

The ticker of the share is NASDAQ:TLRY and it’s already available in the default list of the stock section in EXANTE Trading Platform.

Tilray is the first GMP-certified medical cannabis producer to supply cannabis products to tens of thousands of patients, physicians, pharmacies, hospitals, and researchers. With its branches located in Europe, USA and Canada, it operates all over the world from Chile to New Zealand.

The information in this text is provided to you for informational purposes only and should not be regarded as an offer or solicitation of an offer to buy or sell any investments or related services that may be referenced here.

Canadian medical cannabis producer Tilray launches IPO
Read more

The teams of France, Belgium, England and Croatia made it to the 2018 FIFA World Cup semi-finals. We do not know who will eventually become the world’s champion but can tell you about these countries’ leading stock exchanges.

Created by professionals. For professionals.
Nearest representative office:  EXANTE LTD. (London Branch)
1 Fore Street,
London
EC2Y 9DT, +44 20 3670 9945